Filtros de búsqueda

Lista de obras de Evangelos N Liberopoulos

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses

artículo científico publicado en 2011

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary

scientific article published on 01 September 2011

A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study.

artículo científico publicado en 2016

A patient with new-onset hypercholesterolemia

scientific article published on 23 January 2009

A review of the lipid-related effects of fluvastatin

artículo científico publicado en 2005

A review of the metabolic effects of sibutramine.

artículo científico publicado en 2005

A tumor lysis-like syndrome during therapy of visceral leishmaniasis.

artículo científico publicado en 2002

Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia

artículo científico publicado en 2007

Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes

artículo científico publicado en 2010

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study

artículo científico publicado en 2011

Alcohol intake, serum uric acid concentrations, and risk of gout

artículo científico publicado en 2004

Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension.

artículo científico publicado en 2010

Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.

artículo científico publicado en 2004

Aminoglycoside-induced reversible tubular dysfunction.

artículo científico publicado en 2003

Analysis of antihypertensive effects of statins.

artículo científico publicado en 2007

Anticoagulant drugs: what is new?

artículo científico publicado en 2011

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

artículo científico publicado en 2022

Apolipoprotein E and renal disease.

artículo científico publicado en 2004

Apolipoprotein E polymorphism and the risk of acute nephropathy after cardiac surgery

artículo científico publicado en 2005

Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters

artículo científico publicado en 2004

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

artículo científico publicado en 2002

Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant?

artículo científico publicado en 2009

Are the pleiotropic effects of telmisartan clinically relevant?

scientific article published on January 2009

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

artículo científico publicado en 2011

Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study

artículo científico publicado en 2011

Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort

artículo científico publicado en 2007

Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia

artículo científico publicado en 2001

Attainment of multifactorial treatment targets among the elderly in a lipid clinic

artículo científico publicado en 2015

Autoimmune manifestations in patients with visceral leishmaniasis.

artículo científico publicado en 2012

Beneficial effects of omega-3 fatty acids: the current evidence.

artículo científico publicado en 2006

Bridging the treatment gap in patients at 'extreme' cardiovascular risk: Evidence from a lipid clinic

scientific article published on 14 November 2018

Carbofuran-induced acute pancreatitis.

artículo científico publicado en 2004

Clinical use of Nebivolol in the treatment of chronic heart failure.

artículo científico publicado en 2005

Co-trimoxazole-induced hypouricemia

artículo científico publicado el 1 de marzo de 1998

Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia

artículo científico publicado en 2008

Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.

artículo científico publicado en 2012

Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.

artículo científico publicado en 2006

Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ-activating capacity: effects on high-density lipoprotein subfractions and associated enzymes.

artículo científico publicado en 2013

Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂

scientific article published on 25 February 2011

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout

artículo científico publicado en 2002

Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L).

artículo científico publicado en 2010

Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia

artículo científico publicado en 2013

Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia

artículo científico publicado en 2013

Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.

artículo científico publicado en 2011

Comparison of the efficacy of atorvastatin and micronized fenofibrate in the treatment of mixed hyperlipidemia.

artículo científico publicado en 1999

Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality

scientific article published on 01 November 2008

Could apolipoprotein E polymorphisms be hidden behind the relation between bone mineral density and atherosclerosis in hemodialysis patients? ⬇️

artículo científico publicado el 30 de octubre de 2003

Could statins be useful in the treatment of patients with migraine?

scientific article published on 01 April 2006

Cryoglobulinemic purpura in visceral leishmaniasis.

artículo científico publicado en 2004

Dapagliflozin in patients with type 2 diabetes mellitus.

artículo científico publicado en 2015

Diabetes mellitus and electrolyte disorders.

artículo científico publicado en 2014

Diagnosis and management of the metabolic syndrome in obesity

artículo científico publicado en 2005

Diagnosis of the metabolic syndrome: which definition should we use?

artículo científico publicado en 2005

Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis

artículo científico publicado en 2020

Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

artículo científico publicado en 2007

Diverging trends in cardiovascular morbidity and mortality in a low risk population.

artículo científico publicado en 2009

Do statins have an antiarrhythmic activity?

artículo científico publicado en 2007

Drug combinations for dyslipidemia and obesity treatment in metabolic syndrome.

artículo científico publicado en 2009

Dyslipidaemia, hypercoagulability and the metabolic syndrome

artículo científico publicado en 2006

Dyslipidemia in patients with thyroid disorders

artículo científico publicado en 2002

Early statin therapy in patients with acute coronary syndrome.

artículo científico publicado en 2005

Effect of apolipoprotein E polymorphism on serum uric acid levels in healthy subjects.

artículo científico publicado en 2005

Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.

artículo científico publicado en 2006

Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial

artículo científico

Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemia.

artículo científico publicado en 2013

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

artículo científico publicado en 2006

Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia

artículo científico publicado en 2010

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

artículo científico publicado en 2005

Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin

artículo científico publicado en 2007

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels

artículo científico publicado en 2012

Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients

artículo científico publicado en 2012

Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levels

scientific article published on 02 January 2013

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Ev

scientific article published on 23 September 2006

Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.

artículo científico

Effects of eprosartan on serum metabolic parameters in patients with essential hypertension

artículo científico publicado en 2007

Effects of hormonal treatment on lipids in patients with cancer

artículo científico publicado en 2008

Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.

artículo científico publicado en 2012

Effects of rimonabant, as monotherapy and in combination with fenofibrate or ezetimibe, on plasma adipokine levels: a pilot study.

artículo científico publicado en 2009

Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study

artículo científico publicado en 2010

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients

artículo científico publicado en 2008

Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels

artículo científico publicado en 2012

Effects of thyroid dysfunction on lipid profile. ⬇️

artículo científico publicado en 2011

Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemia

artículo científico publicado en 2009

Electrolyte and acid-base disorders in inflammatory bowel disease

artículo científico publicado en 2013

Electrolyte disturbances in patients with hyponatremia

artículo científico publicado en 2007

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

artículo científico publicado en 2006

Emerging options in the treatment of dyslipidemias: a bright future?

scientific article published on 15 February 2011

Enterococcus casseliflavus bacteremia. Case report and literature review.

artículo científico publicado en 2004

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.

artículo científico publicado en 2019

Exacerbation of tuberculosis enteritis after treatment with infliximab

artículo científico publicado en 2002

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

artículo científico publicado en 2016

Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress

artículo científico publicado en 2011

Ezetimibe-associated adverse effects: what the clinician needs to know.

artículo científico publicado en 2008

Familial hypercholesterolaemia: A global call to arms

artículo científico publicado en 2015

Fenofibrate in primary biliary cirrhosis: a pilot study.

artículo científico publicado en 2010

Fibrate-associated adverse effects beyond muscle and liver toxicity

scientific article published on January 2008

Fibrinogen: a predictor of vascular disease

artículo científico publicado en 2007

Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population.

artículo científico publicado en 2005

Greece: one of the thirty top-performing countries in all scientific fields?

artículo científico publicado en 2005

High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome

artículo científico publicado en 2016

How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.

artículo científico publicado en 2014

How safe is the use of thiazolidinediones in clinical practice?

artículo científico publicado en 2009

Hypocholesterolemia

artículo científico publicado en 2011

Hypokalaemia in alcoholic patients

artículo científico publicado en 2002

Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure

artículo científico publicado en 2002

Hypomagnesemia in a department of internal medicine

scientific article published on 01 December 2012

Hypouricaemia as a marker of a generalized proximal tubular damage in alcoholic patients

artículo científico publicado en 2002

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

artículo científico publicado en 2007

Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.

artículo científico publicado en 2001

Influence of apolipoprotein E polymorphisms on serum creatinine levels and predicted glomerular filtration rate in healthy subjects.

artículo científico publicado en 2004

L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study

artículo científico publicado en 2016

L-carnitine for the treatment of acute myocardial infarction

artículo científico publicado en 2014

Leptospirosis is associated with markedly increased triglycerides and small dense low-density lipoprotein and decreased high-density lipoprotein.

artículo científico publicado en 2011

Life-threatening hypophosphataemia in a cirrhotic patient with jaundice

artículo científico publicado en 2011

Lipid target achievement among patients with very high and high cardiovascular risk in a lipid clinic.

artículo científico publicado en 2014

Lipid testing in infectious diseases: possible role in diagnosis and prognosis

artículo científico publicado en 2017

Lipid-modulating treatments for mixed dyslipidemia increase HDL-associated phospholipase A2 activity with differential effects on HDL subfractions

artículo científico publicado en 2013

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

artículo científico publicado en 2011

Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation

artículo científico publicado en 2017

Lysis syndrome during therapy of visceral leishmaniasis.

artículo científico publicado en 2011

Management of high triglycerides: what non-specialists in lipids need to know.

artículo científico publicado en 2005

Marked hyperphosphataemia in a patient with diabetic ketoacidosis

artículo científico publicado en 2002

Mechanisms of hypocalcemia in alcoholic patients

artículo científico publicado en 2001

Multiple actions of high-density lipoprotein

scientific article published on July 2008

New-onset diabetes after transplantation

New-onset extremely low levels of high-density lipoprotein cholesterol

artículo científico publicado en 2012

No association between high-density lipoprotein levels and ventricular repolarization indexes in subjects with primary hypercholesterolemia

scientific article published on 22 November 2013

No effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemia

artículo científico publicado en 2015

Novel roles of vitamin D in disease: what is new in 2011?

artículo científico publicado en 2011

Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.

artículo científico publicado en 2009

Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinoma

artículo científico publicado en 2007

Pharmacological treatment of non-alcoholic steatohepatitis: the current evidence.

artículo científico publicado en 2007

Pleiotropic effects of fenofibrate

scientific article published on January 2009

Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation

artículo científico publicado en 2011

Pleiotropic effects of thiazolidinediones

artículo científico publicado en 2008

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

artículo científico publicado en 2016

Possible cefotaxime-induced Stevens-Johnson syndrome

artículo científico publicado en 2003

Possible ranitidine-induced cholestatic jaundice

artículo científico publicado en 2002

Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.

artículo científico publicado en 2011

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

artículo científico publicado en 2006

Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.

artículo científico publicado en 2006

Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?

artículo científico publicado en 2015

Reversible proximal tubular dysfunction in a patient with acute febrile illness, marked hyperbilirubinemia and normal renal function: evidence of leptospirosis

scientific article published on 01 July 2002

Review: Antiplatelet drugs: what comes next?

artículo científico publicado en 2010

Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.

artículo científico publicado en 2005

SIADH and hyponatremia with theophylline.

artículo científico publicado en 2002

Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies

scientific article published on 19 October 2020

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

artículo científico publicado en 2011

Serum lipid profile in patients with severe leptospirosis

artículo científico publicado en 2004

Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis

artículo científico publicado en 2002

Should a statin be prescribed to every patient with heart failure?

artículo científico publicado en 2007

Sibutramine-associated adverse effects: a practical guide for its safe use.

artículo científico publicado en 2007

Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes

artículo científico publicado en 2008

Spurious electrolyte disorders: a diagnostic challenge for clinicians.

artículo científico

Statin pleiotropy against renal injury

artículo científico publicado en 2009

Statin therapy with or without ezetimibe and the progression to diabetes

artículo científico publicado en 2015

Statin treatment may be beneficial to both the kidneys and the heart

artículo científico publicado en 2007

Statin-associated adverse effects beyond muscle and liver toxicity

artículo científico publicado en 2006

Statins and solid organ transplantation.

artículo científico publicado en 2006

Statins for non-alcoholic fatty liver disease: a new indication?

artículo científico publicado en 2006

Statins: another class of antihypertensive agents?

artículo científico publicado en 2006

Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.

artículo científico publicado en 2003

Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.

artículo científico publicado en 2001

Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the "treating to new targets" (TNT) trial?

artículo científico publicado en 2005

The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: Role of incorporating low high-density lipoprotein cholesterol levels.

artículo científico publicado en 2017

The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate

artículo científico publicado en 2006

The effect of cholesterol-lowering treatment on renal function

artículo científico publicado en 2006

The effect of combining rosuvastatin with sartans of different peroxisome proliferator receptor-γ activating capacity on plasma 8-isoprostane prostaglandin F2a levels

artículo científico publicado en 2013

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

scientific article published on 05 September 2006

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia

artículo científico publicado en 2011

The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype.

artículo científico publicado en 2001

The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome

artículo científico publicado en 2007

The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide.

artículo científico publicado en 2002

The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol

scientific article published on 01 July 2006

The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic.

artículo científico publicado en 1999

The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients.

artículo científico publicado en 2004

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome.

artículo científico publicado en 2012

The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview

scientific article published on 01 October 2008

The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?

artículo científico publicado en 2007

Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

artículo científico publicado en 2006

Uric acid and incident chronic kidney disease in dyslipidemic individuals.

artículo científico publicado en 2017

Visceral leishmaniasis is associated with marked changes in serum lipid profile

artículo científico publicado en 2014

Visceral leishmaniasis resembling systemic lupus erythematosus

scientific article published on 01 October 2004

Vitamin D and metabolic syndrome: is there a link?

artículo científico publicado en 2010

What restricts the clinical use of nicotinic acid?

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda